Compliance Rate
Compliance Rate
36.0%
Compliant submissions
36
Incompliant submissions
64
Total trials
100
Your Clinical Trials
Showing 25 of 100 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/10/22
End: 01/12/22
Due: 01/13/22
Phase: N/A
Priority: Normal
Start: 01/20/22
End: 01/22/22
Due: 01/23/22
Phase: N/A
Priority: Normal
Start: 01/30/22
End: 02/01/22
Due: 02/02/22
Phase: N/A
Priority: Normal
Start: 02/09/22
End: 02/11/22
Due: 02/12/22
Phase: N/A
Priority: Normal
Start: 02/19/22
End: 02/21/22
Due: 02/22/22
Phase: N/A
Priority: Normal
Start: 03/01/22
End: 03/03/22
Due: 03/04/22
Phase: N/A
Priority: Normal
Start: 03/11/22
End: 03/13/22
Due: 03/14/22
Phase: N/A
Priority: Normal
Start: 03/21/22
End: 03/23/22
Due: 03/24/22
Phase: N/A
Priority: Normal
Start: 03/31/22
End: 04/02/22
Due: 04/03/22
Phase: N/A
Priority: Normal
Start: 04/10/22
End: 04/12/22
Due: 04/13/22
Phase: N/A
Priority: Normal
Start: 09/12/23
End: 09/14/23
Due: 09/15/23
Phase: N/A
Priority: Normal
Start: 02/29/96
End: -
Due: -
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/31/97
End: 06/30/02
Due: 06/30/03
Phase: N/A
Priority: Normal
Start: -
End: 08/31/98
Due: 08/31/99
Phase: N/A
Priority: Normal
Start: 11/30/95
End: 06/30/05
Due: 06/30/06
Phase: N/A
Priority: Normal
Start: 04/30/88
End: 03/31/92
Due: 03/31/93
Phase: N/A
Priority: Normal
Start: 02/28/97
End: 07/31/02
Due: 07/31/03
Phase: N/A
Priority: Normal
Start: 08/31/94
End: -
Due: -
Phase: N/A
Priority: Normal
Start: -
End: 06/30/05
Due: 06/30/06
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: -
End: 03/31/98
Due: 03/31/99
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/28/99
End: 07/31/04
Due: 07/31/05
Phase: N/A
Priority: Normal
Start: -
End: 02/29/96
Due: 02/28/97